US Stock MarketDetailed Quotes

K Kellanova

Watchlist
  • 81.210
  • +0.150+0.19%
Close Jan 3 16:00 ET
  • 81.210
  • 0.0000.00%
Post 16:35 ET
27.99BMarket Cap27.91P/E (TTM)

Kellanova Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kellanova Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.15B
3.23B
+79.93M
Beat Est.
-19.95%
-0.68%
+2.53%
EPS
0.85
1.05
+0.20
Beat Est.
+8.46%
+34.62%
+24.11%
Analyst Rating
Hold

Jan 1, 2025

Kellanova Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.234B--
--2024/Q4-- / 3.104B--
Oct 31, 20242024/Q33.233B / 3.153B--
Aug 1, 20242024/Q23.192B / 3.146B--
May 2, 20242024/Q13.200B / 3.160B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.234B--
--2024/Q4-- / 3.104B--
Oct 31, 20242024/Q33.233B / 3.153B--
Aug 1, 20242024/Q23.192B / 3.146B--
May 2, 20242024/Q13.200B / 3.160B--

Unlock Free Earnings Estimates

Kellanova Earnings Reports

  • Kellanova | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 08:16 ET

  • Kellanova | 8-K: Kellanova Reports Strong Third Quarter Results

    Oct 31, 2024 08:11 ET

  • Kellanova | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 16:22 ET

  • Kellanova | 8-K: Kellanova Reports Strong Second Quarter Results, Raises Full-Year Outlook

    Aug 1, 2024 08:06 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 1, 2025

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data